A kind of intravenous giant cell human immunoglobulin and its preparation method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 哈尔滨派斯菲科生物制药有限公司
- Publication Date
- 2019-04-19
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to therapeutic blood products in the field of biopharmaceuticals, in particular to a giant cell human immunoglobulin and a preparation method thereof. Background technique
[0002] Human cytomegalovirus (HCMV), also known as human herpesvirus type 5 (HHV5), belongs to the betaherpesvirus subfamily. HCMV is one of the most common pathogens of human congenital virus infection, and the infection rate of this virus in adults in my country is as high as 95%. Ordinary people are usually recessive infection, but for immunocompromised populations, such as bone marrow and solid organ transplant recipients, HIV-infected patients and tumor patients, HCMV infection can lead to serious consequences. Primary or recurrent HCMV infection in pregnant women can cause neonatal intrauterine infection or perinatal infection to invade the fetus, which can cause central nervous system involvement, multiple organ damage, mental retardation or deafness i...